Real-world HbA1c changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes.
Saved in:
| Title: | Real-world HbA |
|---|---|
| Authors: | Frazer M; QualityMetric, Johnston, RI USA.; Optum, 11000 Optum Circle Eden Prairie, Eden Prairie, MN 55344 USA., Swift C; Novo Nordisk Inc., Plainsboro, NJ USA., Sargent A; Optum, 11000 Optum Circle Eden Prairie, Eden Prairie, MN 55344 USA., Leszko M; Optum, 11000 Optum Circle Eden Prairie, Eden Prairie, MN 55344 USA., Buysman E; Optum, 11000 Optum Circle Eden Prairie, Eden Prairie, MN 55344 USA., Gronroos NN; Optum, 11000 Optum Circle Eden Prairie, Eden Prairie, MN 55344 USA., Alvarez S; Novo Nordisk Inc., Plainsboro, NJ USA., Dunn TJ; Novo Nordisk Inc., Plainsboro, NJ USA., Noone J; Novo Nordisk Inc., Plainsboro, NJ USA., Gamble CL; Novo Nordisk Inc., Plainsboro, NJ USA. |
| Source: | Journal of diabetes and metabolic disorders [J Diabetes Metab Disord] 2023 Nov 27; Vol. 23 (1), pp. 727-737. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101590741 Publication Model: eCollection Cited Medium: Print ISSN: 2251-6581 (Print) Linking ISSN: 22516581 NLM ISO Abbreviation: J Diabetes Metab Disord Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
